ACS names three new members to board

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Cancer Society announced the election of three new members of its board of directors:

Amit Kumar, of San Jose, CA, executive chairman of ITUS Corporation, a cancer diagnostic company;

Joseph Naylor of San Ramon, CA, vice president of policy, government, and public affairs for Chevron Corp., a position he has held since April 2016.

William Novelli of Bethesda, MD, professor in the McDonough School of Business at Georgetown University and former CEO of AARP.

In other developments:

Arnold Baskies, of Cherry Hill, NJ, became chair of the board. Baskies is a medical director at Virtua Health Systems in southern New Jersey, where he specializes in surgical oncology and general surgery.

Kevin Cullen, of Baltimore, became vice chair. Cullen is the director at the University of Maryland Marlene and Stewart Greenebaum Cancer Center

Lewis Foxhall, of Houston, became board scientific officer. Foxhall is the vice president for health policy and professor of clinical cancer prevention at MD Anderson Cancer Center;

John Alfonso, of Bellerose Village, NY, became sctretary/treadurer. Alfonso is a partner in the CohnReznick LLP New York office and leads the efforts of the firm’s not-for-profit and education industry practice in New York; and

Scarlott Mueller, of Gainesville, FL, became immediate past chair. Mueller is a former vice president and chief nursing officer at the North Florida
Regional Medical Center.

The ACS board consists of 21 members, including five officers and 16 directors. Directors are elected for a two-year term, and officers hold their position for a one-year term. The Board is responsible for setting policy, establishing long-term goals, monitoring general operations, and approving the organizational outcomes and allocation of resources.

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login